triptolide

prostaglandin-endoperoxide synthase 2 ; Homo sapiens







9 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35368759 Exploration of the Immuno-Inflammatory Potential Targets of Xinfeng Capsule in Patients with Ankylosing Spondylitis Based on Data Mining, Network Pharmacology, and Molecular Docking. 2022 1
2 31602908 [Bioinformatics analysis on immune response pathways of triptolide in treating AIDS]. 2019 Aug 1
3 23924856 Triptolide induces apoptosis and inhibits the growth and angiogenesis of human pancreatic cancer cells by downregulating COX-2 and VEGF. 2013 1
4 22093832 Triptolide inhibits COX-2 expression by regulating mRNA stability in TNF-α-treated A549 cells. 2011 Dec 9 7
5 17277882 Triptolide inhibits cyclooxygenase-2 and inducible nitric oxide synthase expression in human colon cancer and leukemia cells. 2007 Feb 1
6 16467309 Cyclooxygenase-2 induction and prostacyclin release by protease-activated receptors in endothelial cells require cooperation between mitogen-activated protein kinase and NF-kappaB pathways. 2006 Apr 28 1
7 15851377 FK506 enhances triptolide-induced down-regulation of cyclooxygenase-2, inducible nitric oxide synthase as well as their products PGE2 and NO in TNF-alpha-stimulated synovial fibroblasts from rheumatoid arthritic patients. 2005 Mar 29 2
8 15067740 [Effect of Triptolide on TNFalpha-induced activation of NF-kappaB and expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts]. 2004 Mar 1
9 12621554 [Enhancement by FK506 of triptolide-induced inhibition of expression of COX-2 and iNOS in human rheumatoid arthritis synovial fibroblasts]. 2003 Mar 2